CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0022
-0.0004 (-15.38%)
Aug 1, 2025, 11:20 AM EDT
CannaPharmaRX Revenue
CannaPharmaRX had revenue of $335.32K in the quarter ending March 31, 2025, with 1,197.72% growth. This brings the company's revenue in the last twelve months to $1.13M, up 4,271.75% year-over-year. In the year 2024, CannaPharmaRX had annual revenue of $820.14K.
Revenue (ttm)
1.13M
Revenue Growth
+4,271.75%
P/S Ratio
1.86
Revenue / Employee
43.45K
Employees
26
Market Cap
2.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 820.14K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
CannaPharmaRX News
- 3 months ago - CannapharmaRx Continues into New European Market with First Shipment Completed to Germany - Accesswire
- 8 months ago - CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy - Accesswire
- 9 months ago - CannapharmaRx to Complete Additional Shipment in November - Accesswire
- 1 year ago - CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product - Accesswire
- 1 year ago - Q1 2024 Financial Results - Accesswire
- 1 year ago - CannapharmaRx Pays Off Convertible Notes - Accesswire
- 1 year ago - CannapharmaRx Receives First Purchase Order and Begins Shipment of Product - Accesswire
- 1 year ago - CannaPharmaRx Completes First Harvests - Accesswire